MOLECULAR RESPONSE TO USTEKINUMAB IN MODERATE-TO-SEVERE CROHN'S DISEASE BY SERUM PROTEIN AND BIOPSY GENE EXPRESSION ANALYSIS: RESULTS FROM USTEKINUMAB PHASE 3 STUDIES

被引：0
|
作者：
Li, Katherine
Hayden, Karen
Wadman, Eric
Bhagat, Sunita
Emrich, Scott
Jacobstein, Douglas
Gasink, Christopher
Brodmerkel, Carrie
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)33341-3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1844
引用
收藏
页码：S986 / S986
页数：1
相关论文
共 50 条
  • [1] Molecular response to ustekinumab in moderate-to-severe Crohn's disease by serum protein and biopsy gene expression analysis: results from Ustekinumab phase 3 studies
    Li, K.
    Hayden, K.
    Wadman, E.
    Bhagat, S.
    Emrich, S.
    Jacobstein, D.
    Gasink, C.
    Brodmerkel, C.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S57 - S58
  • [2] Molecular response to ustekinumab in moderate-to-severe ulcerative colitis by serum protein and biopsy gene expression analysis: Results from the UNIFI Phase 3 induction study
    Li, K.
    Yang, F.
    Hayden, K.
    Strawn, D.
    Wadman, E.
    Bhagat, S.
    Marano, C.
    Friedman, J. R.
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S8 - S9
  • [3] MOLECULAR RESPONSE TO USTEKINUMAB IN MODERATE-TO-SEVERE ULCERATIVE COLITIS BY SERUM PROTEIN AND BIOPSY GENE EXPRESSION ANALYSIS: RESULTS FROM THE UNIFI PHASE 3 INDUCTION STUDY
    Li, Katherine
    Yang, Feifei
    Hayden, Karen
    Strawn, David
    Wadman, Eric
    Bhagat, Sunita
    Marano, Colleen W.
    Friedman, Joshua R.
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S1104 - S1105
  • [4] Molecular response to ustekinumab in moderate-to-severe Crohn's disease by serum protein analysis: results from the UNITI-1 and UNITI-2 Phase 3 induction studies
    Li, K.
    Hayden, K.
    Wadman, E.
    Bhagat, S.
    Emrich, S.
    Friedman, J. R.
    Gasink, C.
    Brodmerkel, C.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S26 - S27
  • [5] Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease
    Peyrin-Biroulet, Laurent
    Chapman, J. Casey
    Colombel, Jean-Frederic
    Caprioli, Flavio
    D'Haens, Geert
    Ferrante, Marc
    Schreiber, Stefan
    Atreya, Raja
    Danese, Silvio
    Lindsay, James O.
    Bossuyt, Peter
    Siegmund, Britta
    Irving, Peter M.
    Panaccione, Remo
    Cao, Qian
    Neimark, Ezequiel
    Wallace, Kori
    Anschutz, Toni
    Kligys, Kristina
    Duan, W. Rachel
    Pivorunas, Valerie
    Huang, Xiu
    Berg, Sofie
    Shu, Lei
    Dubinsky, Marla
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (03): : 213 - 223
  • [6] Molecular Response to Ustekinumab in Moderate-to-Severe Crohn's Disease by Serum Protein Analysis: Results from UNITI-1 Induction, UNITI-2 Induction, and IMUNITI Maintenance Studies
    Li, Katherine
    Hayden, Karen
    Wadman, Eric
    Bhagat, Sunita
    Emrich, Scott
    Friedman, Joshua
    Gasink, Christopher
    Brodmerkel, Carrie
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S377 - S377
  • [7] Molecular Response to Ustekinumab in Moderate-to-Severe Ulcerative Colitis by Serum Protein and Colon Transcriptomic Analysis: Results From the UNIFI Phase 3 Maintenance Study
    Li, Katherine
    Yang, Feifei
    Hayden, Karen
    Strawn, David
    Wadman, Eric
    Bhagat, Sunita
    Marano, Colleen
    Friedman, Joshua R.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S378 - S379
  • [8] Profile of ustekinumab and its potential in patients with moderate-to-severe Crohn's disease
    Tuskey, Anne
    Behm, Brian W.
    [J]. CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2014, 7 : 173 - 179
  • [9] Clinical and molecular characterisation of patients with durable response to ustekinumab induction therapy: Results from the UNIFI phase 3 studies in moderate-to-severe ulcerative colitis
    Li, K.
    Yang, F.
    Hayden, K.
    Strawn, D.
    Wadman, E.
    Bhagat, S.
    Marano, C.
    Friednman, J. R.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S070 - S071
  • [10] CLINICAL AND MOLECULAR CHARACTERIZATION OF PATIENTS WITH DURABLE RESPONSE TO USTEKINUMAB INDUCTION THERAPY: RESULTS FROM THE UNIFI PHASE 3 STUDIES IN MODERATE-TO-SEVERE ULCERATIVE COLITIS
    Li, Katherine
    Yang, Feifei
    Hayden, Karen
    Strawn, David
    Wadman, Eric
    Bhagat, Sunita
    Marano, Colleen W.
    Friedman, Joshua
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S1191 - S1191
12345